Generics 236

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Gabapentin manufacturers

236 products found

Filters

236 products found

gabapentin

Tablets, film coated 600 mg, 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ireland , Sweden , United Kingdom
Manufacturer #20938
In the year the 2000s, it became an independent generic pharmaceutical company. It is one of the few generic pharmaceutical firms dedicated to research with the express goal of providing high-quality, low-cost healthcare to people all around the world. It all began with the goal of developing drugs to prevent, diagnose, treat, and cure diseases.

Manufacturer usually replies in 5 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ireland , Sweden , United Kingdom
Manufacturer #20938
In the year the 2000s, it became an independent generic pharmaceutical company. It is one of the few generic pharmaceutical firms dedicated to research with the express goal of providing high-quality, low-cost healthcare to people all around the world. It all began with the goal of developing drugs to prevent, diagnose, treat, and cure diseases.

Manufacturer usually replies in 5 days

gabapentin

Tablets 600mg, 800mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Poland , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

gabapentin

Capsules 100mg, 300mg, 400mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Poland , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

gabapentin

Tablets, extended release (ER) 300 mg, 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA’s Running
Manufacturer #21467

Manufacturer usually replies in 4 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

gabapentin

Oral solution 250mg/5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

gabapentin

Capsules 100mg, 300mg, 400mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

gabapentin

Tablets, film coated 600 mg, 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

gabapentin

Oral solution 50 mg / mL

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13662
With a countrywide distribution network, it has evolved into one of the leading pharmaceutical corporations in the UK. In business since the 1990s. The company maintains the UK's largest Parallel import license portfolio, operates a customized specialties production facility, is the country's largest independent generics distributor, and is dedicated to providing everyday value to its customers.

Manufacturer usually replies in 13 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg

Dossier type
CTD
Dossier status
Outdated
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Comments
Dossier not suitable for a new registration in EU
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

gabapentin

Oral solution 250 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #19556

Manufacturer usually replies in 5 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg, 600 mg, 800 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18869

Manufacturer usually replies in 6 days

gabapentin

Tablets 600 mg, 800 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17648

Manufacturer usually replies in 8 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17648

Manufacturer usually replies in 8 days

gabapentin

Capsules 100 mg, 300 mg , 400 mg

Dossier type
EU CTD
Dossier status
Outdated
Country of origin
Canada
GMP approvals
EU GMP, Canada
Comments
Dossier is not suitable for a new registration in EU
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

gabapentin

Tablets 800 mg, 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Available for
Licensing with supply, Distribution only
Manufacturer #638

Manufacturer usually replies in 8 days

gabapentin

Capsules 100 mg, 300 mg, 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
France , Portugal , Spain
Available for
Licensing with supply, Distribution only
MAs for sale
Portugal
Manufacturer #638

Manufacturer usually replies in 8 days

gabapentin

Tablets 600 mg, 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Reference product : Neurontin 600 mg and 800 mg (MAH: Pfizer Limited)
Manufacturer #13666

Manufacturer usually replies in 2 days

gabapentin

Capsules, hard liquid 100 mg, 300 mg, 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Reference product : Neurontin 100, 300/400mg hard capsules (MAH: Pfizer Limited)
Manufacturer #13666

Manufacturer usually replies in 2 days

Want to view all 236 products? Create your free account today!

Gabapentin manufacturers

What is Gabapentin?

Gabapentin is a prescription drug in the class of medications known as anticonvulsants. It is used to treat seizures in people with epilepsy, as well as to treat nerve pain and certain other conditions.

Gabapentin works by reducing the activity of nerve cells in the brain and spinal cord. This helps to decrease abnormal electrical activity in the brain that can lead to seizures and also helps to reduce pain signals sent by damaged or overactive nerves.

Gabapentin is available in various forms, including capsules, tablets, and oral solutions. The drug is often used in combination with other medications to treat epilepsy and nerve pain. Gabapentin is sold under various brand names, including Neurontin and Gralise. Gabapentin is a controlled substance in some countries due to its risk of abuse and addiction.

Gabapentin is among the most prescribed medications, with over 44 million yearly prescriptions registered in the United States alone.

Gabapentin forms and dosage

The dosage of Gabapentin depends on the condition being treated and the patient's age, weight, and kidney function.

  • For epilepsy, the typical starting dose of Gabapentin for adults is 300 milligrams (mg) per day, divided into three equal doses. The dose can be increased gradually, up to a maximum of 3,600 mg per day, based on the individual's response and tolerability. For children, the dose is based on their body weight and typically starts at 10-15 mg/kg per day, and is divided into three equal doses.
  • For nerve pain, the typical starting dose of Gabapentin for adults is 300 mg per day, taken either once or twice daily. The dose can be increased gradually, up to a maximum of 3,600 mg per day, based on the individual's response and tolerability. The maximum recommended dose for postherpetic neuralgia (a type of nerve pain caused by shingles) is 1,800 mg per day, divided into three equal doses.
  • For restless legs syndrome, the typical starting dose of Gabapentin for adults is 300 mg daily, taken in the evening. The dose can be increased gradually, up to a maximum of 1,800 mg daily, based on the individual's response and tolerability.

The medication should be taken with food and plenty of water to help prevent stomach upset. Dosages may need to be adjusted for patients with kidney problems, and the medication should not be abruptly stopped without medical supervision.

Gabapentin patent information

The patent for Gabapentin has expired in many countries, including the United States, where it expired in 2004. This means that other manufacturers can now produce and sell generic versions of the medication. However, there may still be patents in effect in some countries that prevent other manufacturers from producing and selling generic versions.

Gabapentin was first developed by the pharmaceutical company Pfizer, and it was initially approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of seizures. Pfizer held the exclusive patent rights for Gabapentin until 2004, when the patent expired, allowing other companies to produce and sell generic versions of the medication.

After the patent expired, Gabapentin became available as a generic medication, which made it more affordable and accessible to patients. However, Pfizer also developed a modified-release formulation of Gabapentin, which is marketed under the brand name Gralise, and this formulation is still under patent in some countries.

Gabapentin manufacturers and brand names

Gabapentin is available under various brand names, including Neurontin, Gralise, Gabarone, Fanatrex, and Horizant.

In addition to the brand-name versions, Gabapentin is also available in generic form, which is sold under various brand names, including Gabapin, Gabantin, Gabamax, and others.

There are many manufacturers of Gabapentin worldwide, including major pharmaceutical companies such as Pfizer, which developed the drug, as well as other companies such as Teva Pharmaceuticals, Mylan, Dr. Reddy's Laboratories, Aurobindo Pharma, Glenmark, Actavis Elizabeth, Aurobindo Pharma, Amneal Pharmaceuticals, Apotex, Sun Pharmaceutical Industries, Hikma Pharmaceuticals, Mutual Pharmaceutical, Sandoz, Watson Laboratories, Akorn, Major Pharmaceuticals, Epic Pharma and others.

Gabapentin wholesale price

Depending on the brand and the quantity purchased, the wholesale prices of Gabapentin in the United States are the following:

  • 100mg capsules cost from around $0.10 to $0.50 per capsule
  • 300mg capsules cost from around $0.20 to $0.60 per capsule, 
  • 600mg tablets cost from around $0.50 to $2.00 per tablet. 

These prices are estimates and can vary depending on various factors.

In the United Kingdom, the National Health Service (NHS) lists the drug tariff price for Gabapentin capsules at £1.67 for a pack of 100 x 100mg capsules and £4.04 for a pack of 100 x 300mg capsules. The drug tariff is the price paid by the NHS to pharmacies for prescription medications, which may differ from the wholesale price.

In other European countries, the wholesale price of Gabapentin may vary, and it is typically lower for generic versions of the medication. For example, in Germany, the wholesale price of generic Gabapentin 300mg capsules ranges from around €0.20 to €0.60 per capsule, while the wholesale price of branded Gabapentin formulations may be higher.

Connecting to Gabapentin manufacturers and suppliers

Pipelinepharma is a B2B platform that connects pharmaceutical buyers with suppliers, manufacturers, and distributors worldwide. The platform can help you find trusted Gabapentin manufacturers in the following ways:

  1. Extensive database of pharmaceutical manufacturers: Pipelinepharma has an extensive database of pharmaceutical manufacturers from around the world, including Gabapentin manufacturers. You can search for manufacturers by product, location, or other criteria and find a list of trusted manufacturers with their contact details.
  2. Verified and registered manufacturers: Pipelinepharma verifies and registers all the manufacturers on its platform to ensure they are legitimate and trustworthy. The platform also provides ratings and reviews of manufacturers from other buyers, which can help you assess their reputation and reliability.
  3. Easy connection to manufacturers: The platform allows you to connect with Gabapentin manufacturers. You can send them inquiries and negotiate prices directly through the platform.
  4. Competitive pricing: Pipelinepharma's platform can help you find Gabapentin manufacturers that offer competitive pricing. You can save money on your next deals by comparing prices and negotiating directly with the manufacturers.
  5. Access to international manufacturers: The platform allows you to access Gabapentin manufacturers from different countries, expanding your options and potentially allowing you to find the best manufacturer for your needs.

In summary, the Pipelinepharma platform provides an easy and efficient way to find trusted Gabapentin manufacturers worldwide through its extensive database of verified and registered manufacturers, easy communication system, competitive pricing, and access to international manufacturers.